Alternatives to ORF Biologics, .

Developing engineered biologics to harness the immune system for disease treatment.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Global marketplace connecting researchers with human biospecimens for life science research.

Biostax provides a cloud-based platform for life sciences research, enabling data integration and analysis.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Biotech startup leveraging bat biology for novel therapeutics in immunology and cardiometabolic diseases.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Mapping cell-cell communication at scale in human tissue.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.